{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:18Z","timestamp":1791297918799,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T00:00:00Z","timestamp":1297641600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0014678","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T22:29:10Z","timestamp":1297722550000},"page":"e14678","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Pharmacologic Modulation of Serine\/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy"],"prefix":"10.1371","volume":"6","author":[{"given":"Lucia","family":"Martiniova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelino","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Lonser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejphar.2009.05.032","article-title":"Impaired DNA damage response\u2013an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy.","volume":"625","author":"Z Darzynkiewicz","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","article-title":"Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.","volume":"8","author":"JE Visvader","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref3","first-page":"2168","article-title":"Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.","volume":"7","author":"MA Shah","year":"2001","journal-title":"Clin Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm.","volume":"9","author":"M Malumbres","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1073\/pnas.72.12.4994","article-title":"Selective killing of transformed baby hamster kidney (BHK) cells.","volume":"72","author":"AB Pardee","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","article-title":"Principles of cancer therapy: oncogene and non-oncogene addiction.","volume":"136","author":"J Luo","year":"2009","journal-title":"Cell"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrd2907","article-title":"Cell cycle kinases as therapeutic targets for cancer.","volume":"8","author":"S Lapenna","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma.","volume":"366","author":"JW Lenders","year":"2005","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma.","volume":"23","author":"L Amar","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma.","volume":"346","author":"HP Neumann","year":"2002","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmg.2008.058560","article-title":"Clinical and molecular progress in hereditary paraganglioma.","volume":"45","author":"BE Baysal","year":"2008","journal-title":"J Med Genet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.","volume":"91","author":"FM Brouwers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1210\/jc.2008-2504","article-title":"The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.","volume":"94","author":"N Burnichon","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12022-008-9047-x","article-title":"Pheochromocytoma: time to stamp out \u201cmalignancy\u201d?","volume":"19","author":"AS Tischler","year":"2008","journal-title":"Endocr Pathol"},{"key":"ref15","first-page":"12","article-title":"Neuroendocrine tumors: review and clinical update.","volume":"51","author":"AM Mougey","year":"2007","journal-title":"Hospital Physician"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/cncr.23812","article-title":"Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.","volume":"113","author":"H Huang","year":"2008","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1210\/jc.2008-2697","article-title":"Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.","volume":"94","author":"K Nomura","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1055\/s-0029-1224135","article-title":"Clinical utility of temozolomide in the treatment of malignant paraganglioma: a preliminary report.","volume":"41","author":"EL Bravo","year":"2009","journal-title":"Horm Metab Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.2000.18.1.158","article-title":"Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.","volume":"18","author":"MR Middleton","year":"2000","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2005.03.6046","article-title":"Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.","volume":"24","author":"MH Kulke","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"11697","DOI":"10.1073\/pnas.0905930106","article-title":"Inhibition of serine\/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.","volume":"106","author":"J Lu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s004410000290","article-title":"Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.","volume":"302","author":"JF Powers","year":"2000","journal-title":"Cell Tissue Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1073\/pnas.181181198","article-title":"A phosphatidylinositol 3-kinase\/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.","volume":"98","author":"LD Mayo","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.onc.1205181","article-title":"Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis.","volume":"21","author":"TM Gottlieb","year":"2002","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/cc.6.1.3682","article-title":"Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events.","volume":"6","author":"MV Blagosklonny","year":"2007","journal-title":"Cell Cycle"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35023629","article-title":"Polo-like kinase-1 is a target of the DNA damage checkpoint.","volume":"2","author":"VA Smits","year":"2000","journal-title":"Nat Cell Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1074\/jbc.M605480200","article-title":"Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.","volume":"282","author":"YJ Jang","year":"2007","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.4161\/cc.8.20.9689","article-title":"Enhancement of cancer chemotherapy by simultaneously altering cell cycle progression and DNA-damage defenses through global modification of the serine\/threonine phospho-proteome.","volume":"8","author":"Z Zhuang","year":"2009","journal-title":"Cell Cycle"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2009.11.016","article-title":"Revealing global regulatory perturbations across human cancers.","volume":"36","author":"H Goodarzi","year":"2009","journal-title":"Mol Cell"},{"key":"ref30","article-title":"Oxabicycloheptanes and oxabicycloheptenes, their preparation and use.","author":"JS Kovach","year":"2008"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.","volume":"22","author":"TC Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref32","article-title":"Increased uptake of [123I]meta-iodobenzylguanidine, [18F]fluorodopamine and [3H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors.","author":"L Martiniova","year":"2010"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1210\/endo.136.11.7588211","article-title":"Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats.","volume":"136","author":"K Pacak","year":"1995","journal-title":"Endocrinology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneumeth.2007.05.024","article-title":"Volumetric neuroimage analysis extensions for the MIPAV software package.","volume":"165","author":"PL Bazin","year":"2007","journal-title":"J Neurosci Methods"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21654","article-title":"Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.","volume":"29","author":"L Martiniova","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e2639","DOI":"10.1371\/journal.pone.0002639","article-title":"Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development.","volume":"3","author":"YJ Chiang","year":"2008","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0014678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T14:50:39Z","timestamp":1560005439000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0014678"}},"subtitle":[],"editor":[{"given":"Joseph Alan","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,14]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0014678","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,14]]}}}